421 related articles for article (PubMed ID: 30122153)
1. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
[TBL] [Abstract][Full Text] [Related]
2. Time- and Dose-Dependent Effects of Hyaluronidase on the Degradation of Different Hyaluronan-Based Fillers In Vitro.
Gerber PA; Buhren BA; Bölke E; Philipp-Dormston WG; Homey B; Schrumpf H
Plast Reconstr Surg; 2023 Mar; 151(3):560-567. PubMed ID: 36730370
[TBL] [Abstract][Full Text] [Related]
3. Degradation of Hylauronic Acid Fillers Using Hyaluronidase in an In Vivo Model.
Ferraz RM; Sandkvist U; Lundgren B
J Drugs Dermatol; 2018 May; 17(5):548-553. PubMed ID: 29742187
[TBL] [Abstract][Full Text] [Related]
4. The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.
Juhász MLW; Levin MK; Marmur ES
Dermatol Surg; 2017 Jun; 43(6):841-847. PubMed ID: 28498207
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro.
Faivre J; Wu K; Gallet M; Sparrow J; Bourdon F; Gallagher CJ
Aesthet Surg J; 2024 May; 44(6):NP402-NP410. PubMed ID: 38366708
[TBL] [Abstract][Full Text] [Related]
6. Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.
Ryu C; Lu JE; Zhang-Nunes S
J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):881-889. PubMed ID: 33308988
[TBL] [Abstract][Full Text] [Related]
7. Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers.
Rao V; Chi S; Woodward J
J Drugs Dermatol; 2014 Sep; 13(9):1053-6. PubMed ID: 25226005
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the Digestion of Cross-Linked Hyaluronic Acid Fillers With Hyaluronidase.
Ugradar S
Dermatol Surg; 2021 Sep; 47(9):1233-1236. PubMed ID: 34115686
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Degradation of Crosslinked Hyaluronic Acid Fillers by Exogenous Hyaluronidases.
Shumate GT; Chopra R; Jones D; Messina DJ; Hee CK
Dermatol Surg; 2018 Aug; 44(8):1075-1083. PubMed ID: 29659410
[TBL] [Abstract][Full Text] [Related]
10. Dose- and time-dependent effects of hyaluronidase on structural cells and the extracellular matrix of the skin.
Buhren BA; Schrumpf H; Gorges K; Reiners O; Bölke E; Fischer JW; Homey B; Gerber PA
Eur J Med Res; 2020 Nov; 25(1):60. PubMed ID: 33228813
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural analysis of 3 hyaluronic acid soft-tissue fillers using scanning electron microscopy.
Flynn TC; Thompson DH; Hyun SH; Howell DJ
Dermatol Surg; 2015 Apr; 41 Suppl 1():S143-52. PubMed ID: 25828039
[TBL] [Abstract][Full Text] [Related]
12.
Zerbinati N; Mocchi R; Galadari H; Maccario C; Maggi M; Rauso R; Passi A; Esposito C; Sommatis S
Biomed Res Int; 2019; 2019():3196723. PubMed ID: 31309104
[TBL] [Abstract][Full Text] [Related]
13. Multidose Hyaluronidase Administration as an Optimal Procedure to Degrade Resilient Hyaluronic Acid Soft Tissue Fillers.
Flégeau K; Jing J; Brusini R; Gallet M; Moreno C; Walker L; Bourdon F; Faivre J
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770671
[TBL] [Abstract][Full Text] [Related]
14. The Myth of the "Biphasic" Hyaluronic Acid Filler.
Öhrlund JÅ; Edsman KL
Dermatol Surg; 2015 Dec; 41 Suppl 1():S358-64. PubMed ID: 26618465
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronidase Caveats in Treating Filler Complications.
Landau M
Dermatol Surg; 2015 Dec; 41 Suppl 1():S347-53. PubMed ID: 26618463
[TBL] [Abstract][Full Text] [Related]
16. The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.
Kim HJ; Kwon SB; Whang KU; Lee JS; Park YL; Lee SY
J Cosmet Laser Ther; 2018 Feb; 20(1):52-57. PubMed ID: 29199877
[TBL] [Abstract][Full Text] [Related]
17. Transvascular Hydrolysis of Hyaluronic Acid Filler With Hyaluronidase: An Ex Vivo Study.
Rauso R; Zerbinati N; Fragola R; Nicoletti GF; Tartaro G
Dermatol Surg; 2021 Mar; 47(3):370-372. PubMed ID: 32932270
[TBL] [Abstract][Full Text] [Related]
18. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.
Cavallini M; Gazzola R; Metalla M; Vaienti L
Aesthet Surg J; 2013 Nov; 33(8):1167-74. PubMed ID: 24197934
[TBL] [Abstract][Full Text] [Related]
19. Fundamental considerations for the use of hyaluronidase, an enzyme for degrading HA fillers.
Hong GW; Yi KH
Skin Res Technol; 2024 Jul; 30(7):e13839. PubMed ID: 38951943
[No Abstract] [Full Text] [Related]
20. Use of hyaluronidase in plastic surgery: A review.
Sharma DSC; Lahiri MA
J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1610-1614. PubMed ID: 34024740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
